セフメタゾール

セフメタゾール 価格 もっと(7)

メーカー	製品番号	製品説明	CAS番号	包装	価格	更新時間	購入
富士フイルム和光純薬株式会社(wako)	W01TRCC242850	セフメタゾール Cefmetazole	56796-20-4	5mg	￥34500	2024-03-01	購入
富士フイルム和光純薬株式会社(wako)	W01TRCC242850	セフメタゾール Cefmetazole	56796-20-4	10mg	￥53400	2024-03-01	購入
富士フイルム和光純薬株式会社(wako)	W01TRCC242850	セフメタゾール Cefmetazole	56796-20-4	50mg	￥213000	2024-03-01	購入
富士フイルム和光純薬株式会社(wako)	W01TRCC242850	セフメタゾール Cefmetazole	56796-20-4	25mg	￥94900	2023-06-01	購入
富士フイルム和光純薬株式会社(wako)	W01TRCC242850	セフメタゾール Cefmetazole	56796-20-4	100mg	￥357800	2023-06-01	購入

セフメタゾール 化学特性,用途語,生産方法

効能

抗生物質, 細胞壁合成阻害薬

説明

Cefmetazole is a cephamycin with a nonaromatic side chain at C-7. In addition to a fairly characteristic second-generation cephalosporin antimicrobial spectrum, it possess fairly significant anti-antiaerobic activity. The ejection of its C-3 side chain leads to alcohol intolerance of the disulfuram type and prolonged clotting times.

一般的な説明

Cefmetazole was synthesized by Sankyo Co. in 1976starting with a biosynthetic cephamycin. It shows excellent activity against Serratia and Proteus, against which cefazolin is not active, and it has stronger activity than cefoxitin, another derivative of cephamycin. Cefmetazole is active against anaerobes and resistant to β-lactamase, but it is not active against Pseudomonas aeruginosa.

化学的特性

White Solid

使用

Semi-synthetic antibiotic derived from Cephamycin. Antibacterial.

定義

ChEBI: A cephalosporin antibiotic containg an N1-methyltetrazol-5-ylthiomethyl side-chain at C-3 of the parent cephem bicyclic structure.

抗菌性

It is active against Pr. mirabilis, Pr. vulgaris, Morganella morganii, Yersinia spp.and most anaerobes. S. marcescens is moderately susceptible, but Ps. aeruginosa and E. faecalis are resistant. It is active against Mycobacterium fortuitum and some strains of M. chelonei. It is resistant to a wide range of β-lactamases.
The serum concentration at the end of a 1 g intravenous infusion is around 77 mg/L. Plasma protein binding is 68%. It is principally excreted in the urine with a plasma half-life of c. 1.3 h; 70% is recovered over the first 6 h. In patients whose creatinine clearance is less than 10 mL/min, plasma levels are elevated and the plasma half-life is increased to around 15 h.
Side effects associated with the methylthiotetrazole group at position C-3 have been reported. Uses are similar to those of cefoxitin, but it is not widely available.

セフメタゾール 上流と下流の製品情報

原材料

準備製品

セフメタゾール 生産企業

名前	電話番号	電子メール	国籍	製品カタログ	優位度
Hebei Mojin Biotechnology Co., Ltd	+86-13288715578 +8613288715578	sales@hbmojin.com	China	12463	58
Shaanxi TNJONE Pharmaceutical Co., Ltd	+8618740459177	sarah@tnjone.com	China	1142	58
Hebei Guanlang Biotechnology Co., Ltd.	+86-19930503282	alice@crovellbio.com	China	8828	58
Xiamen AmoyChem Co., Ltd	+86-592-6051114 +8618959220845	sales@amoychem.com	China	6387	58
Hubei xin bonus chemical co. LTD	86-13657291602	linda@hubeijusheng.com	CHINA	22968	58
CONIER CHEM AND PHARMA LIMITED	+8618523575427	sales@conier.com	China	49391	58
career henan chemical co	+86-0371-86658258 15093356674;	factory@coreychem.com	China	29826	58
Neostar United (Changzhou) Industrial Co., Ltd.	+86-519-519-85557386	marketing1@neostarunited.com	China	12561	58
SIMAGCHEM CORP	+86-13806087780	sale@simagchem.com	China	17367	58
TargetMol Chemicals Inc.	+1-781-999-5354 +1-00000000000	marketing@targetmol.com	United States	19892	58

56796-20-4(セフメタゾール)キーワード:

---

• 56796-20-4
• (6R,7S)-7-[[2-[(CyanoMethyl)thio]acetyl]aMino]-7-Methoxy-3-[[(1-Methyl -1H-tetrazol-5-yl)thio]Methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene -2-carboxylic Acid
• (6r
• 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylicacid,7-((((cyanomethyl)thio)a
• Cefmetazole, 97-103%
• CEFMETAZOLE SODIUM SALT
• Cefmetazole
• Cefatrixine
• 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[[(cyanomethyl)thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, (6R,7S)-
• 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[[(cyanomethyl)thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, (6R-cis)-
• SKF 83088
• U 72791
• U 72791a
• (6R-cis)-7-[[[(Cyanomethyl)thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
• (6R)-7α-[2-(Cyanomethylthio)acetylamino]-7β-methoxy-3-(1-methyl-1H-tetrazol-5-ylthiomethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
• (6R,7S)-7-[[[(Cyanomethyl)thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
• CMZ
• Cefmetazole (200 mg)G0E2600.988mg/mg(ai)
• Cefmetazole (200 mg)
• Ferrous Sulfate (2 x 1 g)
• 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[2-[(cyanomethyl)thio]acetyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-, (6R,7S)-
• (6R,7S)-7-(2-((cyanomethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
• Cefmetazole USP/EP/BP
• CEFMETAZOLE ACID 56796-20-4
• Cefmetazole (1097782)
• Cefmetazolo
• Cefmetazolum
• cs1170
• (6R,7S)-7-(2-((Cyanomethyl)thio)acetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid (Cefmetazole Impurity)
• Cefmetazole, free acid
• (6R)-7-[[[(シアノメチル)チオ]アセチル]アミノ]-7β-メトキシ-3-[[(1-メチル-1H-テトラゾール-5-イル)チオ]メチル]-8-オキソ-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸
• セフメタゾール
• (6R,7S)-7-[2-[(シアノメチル)チオ]アセチルアミノ]-7-メトキシ-3-[[(1-メチル-1H-テトラゾール-5-イル)チオ]メチル]-8-オキソ-5-チア-1-アザビシクロ[4.2.0]オクタン-2-エン-2-カルボン酸
• (6R,7S)-7-[[[(シアノメチル)チオ]アセチル]アミノ]-7-メトキシ-3-[[(1-メチル-1H-テトラゾール-5-イル)チオ]メチル]-8-オキソ-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸
• (6R)-7α-[2-(シアノメチルチオ)アセチルアミノ]-7β-メトキシ-3-(1-メチル-1H-テトラゾール-5-イルチオメチル)-8-オキソ-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸
• (6R,7S)-7-{2-[(シアノメチル)スルファニル]アセトアミド}-7-メトキシ-3-{[(1-メチル-1H-1,2,3,4-テトラゾール-5-イル)スルファニル]メチル}-8-オキソ-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸
• 7β-[2-(シアノメチルチオ)アセトアミド]-7α-メトキシ-3-(1-メチル-1H-テトラゾール-5-イルチオメチル)-8-オキソ-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸
• セファロスポリン類